Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfister

Showing results (451-460 of 754) with videos related to

Pageof 76
Sort By:
Neuro-Oncology|May 28, 2021
Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse modelMilena Simovic, Michiel Bolkestein, Mahmoud Moustafa, et al.
Acta Neuropathologica|July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusionsDamian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Neuropathology and Applied Neurobiology|October 17, 2018
Integrated molecular characterization of IDH-mutant glioblastomasA Korshunov, B Casalini, L Chavez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastomaMarc Remke, Thomas Hielscher, Andrey Korshunov, et al.
Acta Neuropathologica|April 12, 2013
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinLeonille Schweizer, Christian Koelsche, Felix Sahm, et al.
Acta Neuropathologica|April 4, 2023
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratificationJack Goddard, Jemma Castle, Emily Southworth, et al.
Journal of Cancer Research and Clinical Oncology|March 22, 2019
DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcomaChristian Koelsche, Mark Kriegsmann, Felix K F Kommoss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomasKarine Jacob, Dongh-Anh Quang-Khuong, David T W Jones, et al.
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Pageof 76

Showing results (451-460 of 754) with videos related to

Sort By:
Pageof 76
Neuro-Oncology|May 28, 2021
Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse modelMilena Simovic, Michiel Bolkestein, Mahmoud Moustafa, et al.
Acta Neuropathologica|July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusionsDamian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Neuropathology and Applied Neurobiology|October 17, 2018
Integrated molecular characterization of IDH-mutant glioblastomasA Korshunov, B Casalini, L Chavez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastomaMarc Remke, Thomas Hielscher, Andrey Korshunov, et al.
Acta Neuropathologica|April 12, 2013
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinLeonille Schweizer, Christian Koelsche, Felix Sahm, et al.
Acta Neuropathologica|April 4, 2023
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratificationJack Goddard, Jemma Castle, Emily Southworth, et al.
Journal of Cancer Research and Clinical Oncology|March 22, 2019
DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcomaChristian Koelsche, Mark Kriegsmann, Felix K F Kommoss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomasKarine Jacob, Dongh-Anh Quang-Khuong, David T W Jones, et al.
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Pageof 76